Explore News
-
AstraZeneca’s New Weight-Loss Pill Reveals Promising Trial Results
AstraZeneca’s new weight-loss pill has shown promising results in trials
-
Ozempic Butt: New Drug to Stop Muscle Loss
Experts find a solution to the muscle loss side effect of popular weight loss injections
-
Why daraxonrasib is a game-changer for pancreatic cancer treatment
New hope for patients with advanced pancreatic cancer as daraxonrasib shows remarkable efficacy
-
Big Three Insulin Makers Control 90% of Market
The dominance of three pharmaceutical companies over the global insulin market has severe consequences.
-
Apoha Secures $36 Million to Develop New Materials
Apoha’s AI models are set to transform the pharmaceutical and food industries
-
Why Digital Platforms Matter for GLP-1 Access
New models of pharmaceutical access are emerging in the US
-
China Surges in Drug Development, Threatening US Dominance
China’s growing biotech industry sparks concern over US leadership
-
Why Beta Blockers May Be Deadly
Landmark study challenges decades of heart attack treatment, revealing beta blockers’ lack of benefit and…
-
Eli Lilly Surges into Vaccine Market with $4 Billion Acquisition
Eli Lilly expands vaccine portfolio with acquisitions
-
New Weight-Loss Shot Appears to Outperform Other Obesity Drugs on Market
Eli Lilly’s new weight-loss drug helps participants lose up to 28% of body weight
